Mar 9, 2021 Cellectar Granted Japanese Composition of Matter Patent for its Phospholipid-Ether Drug Conjugates Learn More
Mar 2, 2021 Cellectar Reports Financial Results for Year Ended December 31, 2020 and Provides a Corporate Update Learn More